RESTEM Provides Corporate Update and Announces Strategic Priorities for 2026 GlobeNewswire January 08, 2026 MIAMI, Jan. 08, 2026 (GLOBE NEWSWIRE) — RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today provided a corporate update and announced its strategic priorities for 2026. “We had a remarkable […]

CareCloud Brings Wellsoft to Urgent Care with Affinity Deal, Targeting a Larger Nationwide Market Opportunity GlobeNewswire January 08, 2026 SOMERSET, N.J., Jan. 08, 2026 (GLOBE NEWSWIRE) — CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and AI-powered solutions, today announced that Affinity Urgent Care (“Affinity”), a multi-site provider of

GRI Bio Announces Additional Positive Data from Phase 2a Study in Idiopathic Pulmonary Fibrosis, Strengthening Clinical Proof-of-Concept for GRI-0621 GlobeNewswire January 08, 2026 New immune profiling data confirms disease-modifying mechanism, reinforces earlier signals of fibrosis resolution, lung repair, and improved lung function LA JOLLA, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ:

SiTime to Present at the Needham Growth Conference on January 13, 2026 GlobeNewswire January 08, 2026 SANTA CLARA, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) — SiTime Corporation (Nasdaq: SITM), the Precision Timing company, today announced that SiTime's chief executive officer, Rajesh Vashist, will participate at the 28th Annual Needham Growth Conference to be held at

Meltwater Achieves SOC 2 Type II Certification, Reinforcing Commitment to Data Security and Trust GlobeNewswire January 08, 2026 SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) — Meltwater, a global leader in media, social, and consumer intelligence, has achieved SOC 2 Type II certification, underscoring the company's commitment to maintaining the highest standards for data security.

CorMedix Therapeutics Announces Preliminary Fourth Quarter and Full Year 2025 Results and Provides Business Updates GlobeNewswire January 08, 2026 â€' Q4 2025 Unaudited Net Revenue of Approximately $127 million â€' â€' FY 2025 Unaudited Pro Forma Net Revenue of Approximately $400 million â€' â€' Expects Q4 Adjusted EBITDA of Between $77 million and $81 million

Eurasia Group and Royal Bank of Canada Team Up to Reset the Conversation on the US-Canada Relationship New three-year partnership launches ahead of the 2026 USMCA review to strengthen North America's most consequential bilateral relationship GlobeNewswire January 08, 2026 TORONTO, Jan. 08, 2026 (GLOBE NEWSWIRE) — Eurasia Group and Royal Bank of Canada (NYSE: RY)

Zacatecas Silver Provides Corporate Update for 2026 and Highlights Upcoming Drill Program at Silver Project GlobeNewswire January 08, 2026 VANCOUVER, British Columbia, Jan. 08, 2026 (GLOBE NEWSWIRE) — Zacatecas Silver Corp. (TSXV: ZAC | OTCQB: ZCTSF | FRA: 7TV) (“Zacatecas Silver” or the “Company”) is pleased to provide shareholders with a corporate update outlining key

California Resources Corporation and Los Angeles Rams Score in Carbon Management Initiative First year of CRC's “Football Without the Footprint” delivers measurable emissions reduction and local community impact GlobeNewswire January 08, 2026 LONG BEACH, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) — California Resources Corporation (NYSE: CRC) and the Los Angeles Rams today celebrated the first

Humacyte Announces Hospital Charge Data Showing High Expense of Preventable Extremity Arterial Injury Complications GlobeNewswire January 08, 2026 – Data is from comprehensive review of hospital charges and all-payer claims over five years – – Preventable complications such as amputation and conduit infection increased initial hospital charges by approximately $493,000 and $590,000 per patient respectively